Literature DB >> 10669999

Echinococcal liver cysts: treatment with echo-guided percutaneous puncture PAIR for echinococcal liver cysts.

F G Crippa1, R Bruno, E Brunetti, C Filice.   

Abstract

In spite of recent progress, treatment for liver echinococcal cysts is still far from satisfying. In recent years, percutaneous drainage has been increasingly used for this purpose and it has been shown to be an effective alternative to surgery and chemotherapy alone. This technique is known as PAIR, from Puncture, Aspiration, Injection (of a scolecidal agent), Reaspiration: here we present our experience and the state of the art of PAIR. Patients from Italy and Turkana (Kenya), harbouring 233 Gharbi type I, II and III echinococcal cysts were successfully treated with PAIR: it was performed according to protocols established at the Division of Infectious and Tropical Diseases, IRCCS--Policlinico S. Matteo, University of Pavia. In Italy, one relapse was recorded, four years after the procedure; the patient was treated again with PAIR; no cases of anaphylactic shock or peritoneal dissemination were observed in a follow-up of 10 years; only 10 minor complications (biliary fistula, urticarioid reaction, abscessualization of the cyst, anaphylactoid reactions) were reported. Long-term results indicate that in Gharbi type I, II and III echinococcal cysts, and in developing countries, in particular, PAIR is a first choice method for the treatment of abdominal localizations of this disease.

Entities:  

Mesh:

Year:  1999        PMID: 10669999

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  2 in total

1.  Percutaneous treatment of univesicular versus multivesicular hepatic hydatid cysts.

Authors:  E Zerem; R Jusufovic
Journal:  Surg Endosc       Date:  2006-08-01       Impact factor: 4.584

2.  Laparoscopic treatment of hepatic hydatid cysts with a liposuction device.

Authors:  Zain Al-Shareef; Osman A Hamour; Saud Al-Shlash; Inam Ahmed; Abbas A Mohamed
Journal:  JSLS       Date:  2002 Oct-Dec       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.